Datroway (datopotamab deruxtecan)

Datroway (datopotamab Deruxtecan-dlnk) is a Trop-2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of:

• adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) who have received prior EGFR-directed therapy and platinum-based chemotherapy.
• This indication is approved under accelerated approval based on objective response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trial.

adult patients with unresectable or metastatic, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.

Recommended Dosage:
The recommended dosage of Datroway is 6 mg/kg (up to a maximum of 540 mg for patients ≥90 kg) administered as an intravenous infusion once every 3 weeks (21-day cycle) until there is evidence of disease progression or unacceptable toxicity. If a planned dose is delayed or missed, administer as quickly as possible; do not wait until the next planned cycle. Adjust the schedule of administration to maintain a 3-week interval between doses.

• Treatment with Datroway injection may sometimes cause serious lung complications such as interstitial lung disease (ILD) or pneumonitis. Monitor patients for fever, cough, shortness of breath, or other respiratory symptoms. Interrupt treatment if suspected and permanently stop for serious cases. Quick medical evaluation and supportive care are required.
• This medicine may cause ocular-related side effects, including dry eyes, keratitis, blurred vision, and conjunctivitis. Patients should report any redness, eye discomfort, or vision changes quickly. Regular ophthalmologic monitoring is required. Supportive treatments like lubricating eye drops can be used to manage symptoms.
• Stomatitis, including mouth sores and inflammation, may happen during this treatment. Monitor patients for oral pain, ulcers, or difficulty eating. Practice good oral hygiene. Treatment interruption, dose adjustment, or supportive care may be required to manage critical symptoms.
• This medicine may cause harm to an unborn baby when administered during pregnancy. Women of reproductive potential should use a proper contraception during treatment and for a recommended period afterward. Inform patients about potential risks and advise immediate medical consultation if pregnancy occurs.
• It is not known whether Datroway passes into human breast milk. Because of the potential risk of serious adverse reactions in breastfed infants, avoid breastfeeding during treatment and for a period after the final dose of Datroway therapy.

What documents are required to import DATROWAY to India?

DATROWAY (datopotamab deruxtecan-dlnk) injection can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is DATROWAY available in India?

DATROWAY (datopotamab deruxtecan-dlnk injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Datroway in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  Datroway price in India.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

DATROWAY can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of DATROWAY (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91 98104 69557 | Toll-Free Number: 1800-1200-365 or write us at info@indianpharmanetwork.in for the Datroway cost in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source DATROWAY (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Datroway®?

Datopotamab deruxtecan-dlnk is the Generic Name for the trade name drug Datroway®.

What is the Manufacturer’s Name of Datroway®?

Datroway® is manufactured by Daiichi Sankyo, Inc.

Is Datroway approved by the FDA?

Yes. Datroway is approved by the FDA. Date of first approval: January 17, 2025.

What is the dosage and form of Datroway® supplied?

Datroway is supplied for Injection: 100 mg lyophilized powder in a single-dose vial for intravenous (IV) use.

What are the most common side effects of Datroway® injection?

The most commonly reported side effects of Datroway® are stomatitis, nausea, fatigue, alopecia, constipation, dry eye, vomiting, keratitis, stomatitis, nausea, alopecia, fatigue, constipation, decreased appetite, musculoskeletal pain, and rash.

How does Datroway Import in India work?

Datroway Import in India is possible through the Named Patient Program. This means the medicine can be imported for a specific patient with a valid doctor’s prescription. Indian Pharma Network helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.

Who is a reliable Datroway supplier in India?

Indian Pharma Network is a trusted Datroway supplier in India, facilitating compliant access through global sourcing channels and structured documentation support for eligible patients under applicable regulatory provisions.

How much does Datroway® injection cost in India?

Datroway® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Datroway prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Datroway cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.

Can Datroway® injection be available in SAARC countries?

Apart from Gulf countries, Datroway® injection can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Datroway® injection in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Datroway® injection online in India?

Yes, one can buy Datroway in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the supply of Datroway® injection through legal channels.

Who is an authorized Datroway importer in India?

Indian Pharma Network acts as a Datroway importer in India, assisting with Named Patient import processes, regulatory documentation, and compliant international procurement for patients requiring this therapy.

What are the storage conditions of Datroway® injection?

Store vials in a refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light until time of reconstitution. It is not advisable to freeze it. Avoid shaking the reconstituted or diluted solution.